Home › Seizures › North Carolina
Seizures clinical trials in North Carolina
11 studies for Seizures are looking for participants at sites in North Carolina.
Cities in North Carolina
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Atrium Health STRIVE Research, Charlotte
- On-Site Clinical Solution, Charlotte
- Duke University Medical Center, Durham
- and 1 more
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Oct 2, 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Onsite Clinical Solutions, Charlotte
- Velocity Clinical Research at Raleigh Neurology, Raleigh
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Asheville Neurology Specialists, Asheville
- OnSite Clinical Solutions, LLC, Charlotte
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Asheville Neurology Specialists, Asheville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Duke University Health System, Durham
- Science 37, Morrisville
- Wake Forest Baptist Medical Center, Winston-Salem
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Velocity Clinical Research, Raleigh
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Atrium Health, Charlotte
- Duke University Hospital, Durham
- Atrium Wake Forest Baptist, Winston-Salem
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Duke University Clinic, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100Oxygen Toxicity: Mechanisms in Humans
- Duke University Health Sustem, Durham
RecruitingHealthy volunteers welcome
Ages 18 to 45 · All sexes · Updated Oct 23, 2025 · NCT05761756Pediatric Dose Optimization for Seizures in Emergency Medical Services
- Mecklenburg EMS, Charlotte
RecruitingPhase 3
6 Months – 13 Years · All sexes · Updated Sep 30, 2025 · NCT05121324Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Duke University Clinical Research at Pickett Road, Durham
RecruitingPhase 3
Ages 4 to 55 · All sexes · Updated Jul 24, 2025 · NCT05219617From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.